| Financial Year |
March 31 2023 |
| Monetary Funds |
558,693,100.55 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
79,520,896.65 |
| Accounts Receivable |
108,743,931.49 |
| Advances to Suppliers |
9,005,920.58 |
| Other Receivables |
73,142.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
88,479,024.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,201,319.44 |
| Total Current Assets |
856,717,336.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
33,959.43 |
| Fixed Assetes |
656,609,109.68 |
| Under-construction Projects |
61,312,359.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
54,898,911.06 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,976,184.79 |
| Deferred Income Tax Assets |
10,057,504.10 |
| Other Non-Current Assets |
38,018,017.24 |
| Sub-Total of Non-Current Assets |
829,906,045.46 |
| Total Assets |
1,686,623,381.84 |
| Short-Term Loans |
107,107,601.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
31,880,749.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,626,374.47 |
| Taxes Payable |
5,363,679.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,556,749.67 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
680,995.76 |
| Sub-Total of Current Liabilities |
162,587,375.68 |
| Long-term Loans |
10,009,777.78 |
| Bonds Payable |
307,451,341.97 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,429,007.30 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
341,537,322.05 |
| Total Liabilities |
504,124,697.73 |
| Paid-In Capital(Or Share Stock) |
400,451,000.00 |
| Capital Surplus |
406,274,341.44 |
| Surplus Reserve |
67,482,934.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
303,825,655.26 |
| Minority Stockholder's Interest |
4,464,753.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,178,033,930.93 |
| Owner's Equity（Stockholder's Equity） |
1,182,498,684.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,686,623,381.84 |
